Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Pharmacy Chain 36.6 reported for 3 months of 2024 by RAS

4/24/24 APTK

Vedernikov Winery in 2023 sold more than 1 million bottles

4/24/24 ABRD

ITC reported for 3 months of 2024 by RAS

4/24/24 WTCM

Freedom.bi ahead of schedule has raised minimal amounts of success

4/24/24 OTCI

RusHydro's output in Q1 increased by 7.2%

4/24/24 HYDR

NCSP reports for 3 months of 2024 by RAS

4/24/24 NMTP

Severstal to increase its share in the steel structures market to 11%

4/24/24 CHMF

Tambovenergosbyt reported for 3 months of 2024 by RAS

4/24/24 TASB

Tinkoff will launch new assistants without Oleg's assistant

4/24/24 T

Novatek started production at the Severo-Chaselskoye field

4/24/24 NVTK